Effects of Bifidobacterium breve 207-1 on regulating lifestyle behaviors and mental wellness in healthy adults based on the microbiome-gut-brain axis: a randomized, double-blind, placebo-controlled trial.
Jinxing LiYapeng LiJincheng ZhaoLiang LiYunyi WangFei ChenYuchen LiRuyue ChengFang HeXiaolei ZeXi ShenPublished in: European journal of nutrition (2024)
This trial was retrospectively registered in the Chinese Clinical Trial Registry under the accession number ChiCTR2300069453 on March 16, 2023.
Keyphrases
- double blind
- clinical trial
- phase iii
- phase ii
- placebo controlled
- study protocol
- resting state
- metabolic syndrome
- white matter
- mental health
- weight loss
- cardiovascular disease
- physical activity
- open label
- functional connectivity
- randomized controlled trial
- cerebral ischemia
- multiple sclerosis
- blood brain barrier
- type diabetes